HCG (Human Chorionic Gonadotropin) vs Lanreotide
Overview
HCG (Human Chorionic Gonadotropin) and Lanreotide are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares HCG (Human Chorionic Gonadotropin) and Lanreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| HCG (Human Chorionic Gonadotropin) | Lanreotide | |
|---|---|---|
| Category | Hormonal | Hormonal |
| Regulatory status (US) | Research use only | FDA approved |
| Typical dosage | 250-500 IU | 60-120 mg |
| Frequency | multiple weekly | every 4 weeks |
| Reported benefits | Testosterone support, fertility, testicular health | suppression of excess growth hormone and IGF-1 in acromegaly, improved progression-free survival in GEP-NETs, reduction of carcinoid syndrome symptoms, inhibition of multiple GI and pancreatic hormones |
| Reported side effects | Possible estrogen increase, injection site reactions | diarrhea, cholelithiasis, abdominal pain, hyperglycemia, bradycardia, injection site reactions, nausea, hypertension, headache, thyroid function decreases |
Key differences
Primary use. HCG (Human Chorionic Gonadotropin) is categorised under Hormonal, while Lanreotide falls under Hormonal. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. HCG (Human Chorionic Gonadotropin): not FDA-approved; treated as a research compound. Lanreotide: FDA-approved.
Dosing. HCG (Human Chorionic Gonadotropin) is typically dosed at 250-500 IU (multiple weekly). Lanreotide is typically dosed at 60-120 mg (every 4 weeks).
Can you stack them?
Some protocols combine peptides, but stacking HCG (Human Chorionic Gonadotropin) and Lanreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between HCG (Human Chorionic Gonadotropin) and Lanreotide?
- HCG (Human Chorionic Gonadotropin) and Lanreotide are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status. HCG (Human Chorionic Gonadotropin) is not FDA-approved; generally classified as a research compound, whereas Lanreotide is FDA-approved for one or more indications.
- What is HCG (Human Chorionic Gonadotropin) used for?
- Testosterone production support.
- What is Lanreotide used for?
- FDA-approved long-acting somatostatin analog for acromegaly, GEP-NETs, and carcinoid syndrome.
- Can you take HCG (Human Chorionic Gonadotropin) and Lanreotide together?
- Some users combine peptides within a single protocol, but stacking HCG (Human Chorionic Gonadotropin) and Lanreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is HCG (Human Chorionic Gonadotropin) or Lanreotide FDA-approved?
- HCG (Human Chorionic Gonadotropin) is not FDA-approved; generally classified as a research compound. Lanreotide is FDA-approved for one or more indications.
Read the full articles
- HCG (Human Chorionic Gonadotropin) — full monograph: mechanism, research, dosing & references
- Lanreotide — full monograph: mechanism, research, dosing & references